X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
research (2) 2
adult (1) 1
adverse event (1) 1
aged (1) 1
alirocumab (1) 1
antibodies (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
bone-marrow-transplantation (1) 1
cerebral cortex - diagnostic imaging (1) 1
chronic lymphocytic-leukemia (1) 1
clinical neurology (1) 1
complications and side effects (1) 1
databases, factual - statistics & numerical data (1) 1
development and progression (1) 1
dna - cerebrospinal fluid (1) 1
dosage and administration (1) 1
double-blind (1) 1
drug-reactions (1) 1
drugs (1) 1
efficacy (1) 1
evolocumab (1) 1
female (1) 1
humans (1) 1
hypercholesterolemia (1) 1
immunologic factors - therapeutic use (1) 1
immunosuppressive agents (1) 1
index medicus (1) 1
jc virus - genetics (1) 1
leukoencephalopathy, progressive multifocal (1) 1
leukoencephalopathy, progressive multifocal - cerebrospinal fluid (1) 1
leukoencephalopathy, progressive multifocal - classification (1) 1
leukoencephalopathy, progressive multifocal - diagnosis (1) 1
leukoencephalopathy, progressive multifocal - therapy (1) 1
long-term survival (1) 1
male (1) 1
medication (1) 1
medicine & public health (1) 1
metaanalysis (1) 1
middle aged (1) 1
multiple-sclerosis patients (1) 1
natalizumab - therapeutic use (1) 1
natalizumab-associated pml (1) 1
netherlands (1) 1
neuroimaging (1) 1
neurology (1) 1
neuroradiology (1) 1
neurosciences (1) 1
non-hodgkin-lymphoma (1) 1
of-the-literature (1) 1
original communication (1) 1
pharmacology & pharmacy (1) 1
pharmacovigilance (1) 1
progressive multifocal leukoencephalopathy (1) 1
reconstitution inflammatory syndrome (1) 1
risk factors (1) 1
safety (1) 1
side effect (1) 1
stem-cell transplantation (1) 1
systemic-lupus-erythematosus (1) 1
trials (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pharmaceutisch Weekblad, ISSN 0031-6911, 02/2017, Volume 152, Issue 6, pp. 20 - 21
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2019, Volume 105, Issue 2, pp. 496 - 504
In randomized clinical trials ( RCT s) proprotein convertase subtilisin/kexin 9 ( PCSK 9) inhibitors showed a favorable safety profile, however, “real‐world”... 
ANTIBODIES | DRUG-REACTIONS | TRIALS | ALIROCUMAB | METAANALYSIS | EFFICACY | SAFETY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HYPERCHOLESTEROLEMIA | EVOLOCUMAB | Research
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2019, Volume 105, Issue 2, pp. 496 - 504
Journal Article
Journal of Neurology, ISSN 0340-5354, 2016, Volume 263, Issue 10, pp. 2004 - 2021
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.